论文部分内容阅读
目的:探究同步放化疗治疗中晚期宫颈癌的临床疗效。方法:选取本院于2013年8月至2016年3月收治的中晚期宫颈癌患者98例,按数字表法随机分为观察组和对照组各49例,对照组患者进行单纯放疗治疗,观察组在对照组的基础之上结合化疗进行同步治疗,对比两组患者治疗后一个月后的临床治疗效果以及生存率等。结果:经比较发现,两组均能达到治疗效果,但观察组治疗后患者的生存率明显高于对照组,差异明显(p<0.05)。结论:同步放化疗治疗能够有效降低患者的死亡率,提高治疗效果,降低患者复发的可能。
Objective: To explore the clinical efficacy of concurrent chemoradiotherapy in the treatment of advanced cervical cancer. Methods: A total of 98 patients with advanced cervical cancer who were treated in our hospital from August 2013 to March 2016 were randomly divided into observation group (49 cases) and control group (49 cases) according to the digital meter method. Patients in the control group received radiotherapy alone In the control group based on the combination of chemotherapy for synchronous treatment, compared two groups of patients after treatment one month after the clinical treatment and survival rates. Results: The results showed that both groups could achieve the therapeutic effect, but the survival rate of the observation group was significantly higher than that of the control group (p <0.05). Conclusions: Concurrent concurrent chemoradiotherapy can effectively reduce the mortality of patients, improve the therapeutic effect and reduce the possibility of recurrence.